Researchers have discovered an existing lung cancer drug may be effective against the disease.
Renal cell carcinoma is one of the most common cancers in the UK and US and has a 50 per cent mortality rate, partially because three in five patients show no symptoms until the cancer is at a late stage.
Now, a study into the cancer at single-cell level has discovered canakinumab could prevent RCC from forming or progressing. The Daily Mail
See also:
- Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer (open access) Cancer Cell
No comments:
Post a Comment